Rauch F - Search Results

1

A standard set of outcome measures for the comprehensive assessment of osteogenesis imperfecta.

Nijhuis W, Franken A, Ayers K, Damas C, Folkestad L, Forlino A, Fraschini P, Hill C, Janus G, Kruse R, Lande Wekre L, Michiels L, Montpetit K, Panzeri L, Porquet-Bordes V, Rauch F, Sakkers R, Salles JP, Semler O, Sun J, To M, Tosi L, Yao Y, Yeung EHK, Zhytnik L, Zillikens MC, Verhoef M. Nijhuis W, et al. Among authors: rauch f. Orphanet J Rare Dis. 2021 Mar 20;16(1):140. doi: 10.1186/s13023-021-01682-y. Orphanet J Rare Dis. 2021. PMID: 33743784 Free PMC article.

2

Pamidronate treatment of severe osteogenesis imperfecta in children under 3 years of age.

Plotkin H, Rauch F, Bishop NJ, Montpetit K, Ruck-Gibis J, Travers R, Glorieux FH. Plotkin H, et al. Among authors: rauch f. J Clin Endocrinol Metab. 2000 May;85(5):1846-50. doi: 10.1210/jcem.85.5.6584. J Clin Endocrinol Metab. 2000. PMID: 10843163 Clinical Trial.

3

Osteogenesis imperfecta type VII maps to the short arm of chromosome 3.

Labuda M, Morissette J, Ward LM, Rauch F, Lalic L, Roughley PJ, Glorieux FH. Labuda M, et al. Among authors: rauch f. Bone. 2002 Jul;31(1):19-25. doi: 10.1016/s8756-3282(02)00808-6. Bone. 2002. PMID: 12110407

4

Rapid increase in grip force after start of pamidronate therapy in children and adolescents with severe osteogenesis imperfecta.

Montpetit K, Plotkin H, Rauch F, Bilodeau N, Cloutier S, Rabzel M, Glorieux FH. Montpetit K, et al. Among authors: rauch f. Pediatrics. 2003 May;111(5 Pt 1):e601-3. doi: 10.1542/peds.111.5.e601. Pediatrics. 2003. PMID: 12728117

5

Osteogenesis imperfecta--clinical and molecular diversity.

Roughley PJ, Rauch F, Glorieux FH. Roughley PJ, et al. Among authors: rauch f. Eur Cell Mater. 2003 Jun 30;5:41-7; discussion 47. doi: 10.22203/ecm.v005a04. Eur Cell Mater. 2003. PMID: 14562271 Free article. Review.

6

Osteogenesis imperfecta.

Rauch F, Glorieux FH. Rauch F, et al. Lancet. 2004 Apr 24;363(9418):1377-85. doi: 10.1016/S0140-6736(04)16051-0. Lancet. 2004. PMID: 15110498 Review.

7

Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long?

Rauch F, Glorieux FH. Rauch F, et al. Ann Med. 2005;37(4):295-302. doi: 10.1080/07853890510007386. Ann Med. 2005. PMID: 16019729 Free article. Review.

8

Osteogenesis imperfecta, current and future medical treatment.

Rauch F, Glorieux FH. Rauch F, et al. Am J Med Genet C Semin Med Genet. 2005 Nov 15;139C(1):31-7. doi: 10.1002/ajmg.c.30072. Am J Med Genet C Semin Med Genet. 2005. PMID: 16278881

9

Effect of intravenous pamidronate therapy on functional abilities and level of ambulation in children with osteogenesis imperfecta.

Land C, Rauch F, Montpetit K, Ruck-Gibis J, Glorieux FH. Land C, et al. Among authors: rauch f. J Pediatr. 2006 Apr;148(4):456-60. doi: 10.1016/j.jpeds.2005.10.041. J Pediatr. 2006. PMID: 16647404 Clinical Trial.

10

Hyperplastic callus formation in osteogenesis imperfecta type V: follow-up of three generations over ten years.

Cheung MS, Azouz EM, Glorieux FH, Rauch F. Cheung MS, et al. Among authors: rauch f. Skeletal Radiol. 2008 May;37(5):465-7. doi: 10.1007/s00256-007-0441-0. Epub 2008 Feb 7. Skeletal Radiol. 2008. PMID: 18256825

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

449 results

Search Page

Filters